SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 145 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $544 | -30.5% | 37,433 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $783 | -1.0% | 37,433 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $791 | -23.7% | 37,433 | -8.1% | 0.01% | -27.3% |
| Q4 2022 | $1,037 | -99.9% | 40,734 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $979,000 | -2.9% | 40,734 | -29.8% | 0.01% | +10.0% |
| Q1 2022 | $1,008,000 | -9.0% | 57,994 | +14.6% | 0.01% | 0.0% |
| Q4 2021 | $1,108,000 | +14.6% | 50,610 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $967,000 | +29.1% | 50,610 | +16.0% | 0.01% | +28.6% |
| Q2 2021 | $749,000 | -23.2% | 43,618 | 0.0% | 0.01% | -30.0% |
| Q1 2021 | $975,000 | +119.6% | 43,618 | +118.6% | 0.01% | +150.0% |
| Q4 2020 | $444,000 | – | 19,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |